scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1517/17460441.2015.1049529 |
P698 | PubMed publication ID | 26073097 |
P50 | author | Henna Myllymäki | Q59668409 |
P2093 | author name string | Mika Rämet | |
Mirja Niskanen | |||
Kaisa E Oksanen | |||
P2860 | cites work | Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis | Q22242062 |
Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis | Q24170218 | ||
Host-pathogen interactions made transparent with the zebrafish model | Q24604664 | ||
Defining features of protective CD4 T cell responses to Mycobacterium tuberculosis | Q27022371 | ||
A humanized mouse model of tuberculosis | Q27320865 | ||
Vaccination with a BCG strain overexpressing Ag85B protects cattle against Mycobacterium bovis challenge | Q27331427 | ||
A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data | Q28383049 | ||
Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus) | Q28386031 | ||
The ongoing challenge of latent tuberculosis | Q28386135 | ||
Ipr1 gene mediates innate immunity to tuberculosis | Q28585986 | ||
Three-dimensional in vitro models of granuloma to study bacteria-host interactions, drug-susceptibility, and resuscitation of dormant mycobacteria | Q28658279 | ||
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection | Q29616521 | ||
Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates | Q29618010 | ||
Disseminated tuberculosis in interferon gamma gene-disrupted mice | Q29619812 | ||
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial | Q29620144 | ||
Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing | Q30227121 | ||
Novel vaccination strategies against tuberculosis. | Q30363188 | ||
The role of the granuloma in expansion and dissemination of early tuberculous infection | Q30502401 | ||
Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death | Q30502462 | ||
Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes | Q31154479 | ||
Evaluation of standard chemotherapy in the guinea pig model of tuberculosis | Q33826439 | ||
Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice | Q33826578 | ||
Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs | Q33947806 | ||
Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. | Q34007030 | ||
Perspectives on Clinical and Preclinical Testing of New Tuberculosis Vaccines | Q34189865 | ||
Cough aerosols of Mycobacterium tuberculosis predict new infection: a household contact study | Q34322008 | ||
Mycobacterium marinum causes a latent infection that can be reactivated by gamma irradiation in adult zebrafish | Q34426515 | ||
Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial | Q34663035 | ||
Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis | Q34769170 | ||
Infection by tubercular mycobacteria is spread by nonlytic ejection from their amoeba hosts | Q34969920 | ||
Intracellular replication of Mycobacterium marinum within Dictyostelium discoideum: efficient replication in the absence of host coronin | Q35013023 | ||
Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish | Q35047245 | ||
Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism | Q35051649 | ||
Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis | Q35147207 | ||
Adequate Th2-type response associates with restricted bacterial growth in latent mycobacterial infection of zebrafish | Q35195622 | ||
Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset. | Q35214233 | ||
Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity | Q35217489 | ||
Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis | Q35549372 | ||
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis | Q35647253 | ||
Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis | Q35778099 | ||
New models for the study of Mycobacterium-host interactions | Q35832065 | ||
Conjunctival vaccination of the brushtail possum (Trichosurus vulpecula) with bacille Calmette-Guérin. | Q43466585 | ||
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti | Q44056191 | ||
Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara | Q45722508 | ||
Akt and FOXO dysregulation contribute to infection-induced wasting in Drosophila | Q46061846 | ||
Flotillin and RacH modulate the intracellular immunity of Dictyostelium to Mycobacterium marinum infection | Q46473864 | ||
Method for assessing IFN-γ responses in guinea pigs during TB vaccine trials | Q46493610 | ||
Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis | Q46629613 | ||
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials | Q46851619 | ||
Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension | Q46915063 | ||
Superinfecting mycobacteria home to established tuberculous granulomas | Q47281542 | ||
Experimental aerosol Mycobacterium bovis model of infection in goats | Q48015954 | ||
Microscopical and immunological features of tuberculoid granulomata and cavitary pulmonary tuberculosis in naturally infected goats. | Q54386955 | ||
Bacille Calmette-Guerin vaccination: the current situation in Europe | Q56838149 | ||
ExperimentalMycobacterium tuberculosisInfection of Cynomolgus Macaques Closely Resembles the Various Manifestations of HumanM. tuberculosisInfection | Q36044482 | ||
Different Strains ofMycobacterium tuberculosisCause Various Spectrums of Disease in the Rabbit Model of Tuberculosis | Q36046773 | ||
Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months. | Q36154690 | ||
Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis | Q36191665 | ||
Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy | Q36263128 | ||
The pathogenesis and pathology of bovine tuberculosis with insights from studies of tuberculosis in humans and laboratory animal models | Q36323872 | ||
Spontaneous latency in a rabbit model of pulmonary tuberculosis. | Q36355577 | ||
On the response of genetically resistant and susceptible rabbits to the quantitative inhalation of human type tubercle bacilli and the nature of resistance to tuberculosis | Q36399991 | ||
Susceptibility to tuberculosis: composition of tuberculous granulomas in Thorbecke and outbred New Zealand White rabbits | Q36571064 | ||
Susceptibility to tuberculosis: clues from studies with inbred and outbred New Zealand White rabbits | Q36575821 | ||
Prokaryotic expression and in vitro functional analysis of IL-1β and MCP-1 from guinea pig. | Q36675666 | ||
Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages | Q36802876 | ||
Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits | Q37151979 | ||
Accuracy and coverage assessment of Oryctolagus cuniculus (rabbit) genes encoding immunoglobulins in the whole genome sequence assembly (OryCun2.0) and localization of the IGH locus to chromosome 20. | Q37191641 | ||
What animal models teach humans about tuberculosis | Q37192066 | ||
The ubiquitin ligase parkin mediates resistance to intracellular pathogens | Q37458253 | ||
Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids | Q37653944 | ||
Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies | Q37866535 | ||
Tuberculosis pathogenesis and immunity | Q37952831 | ||
Revisiting the role of the granuloma in tuberculosis | Q38003929 | ||
The fruit fly Drosophila melanogaster unfolds the secrets of innate immunity | Q38011192 | ||
The zebrafish as a model for paediatric diseases | Q38038272 | ||
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis | Q38039763 | ||
Mycobacterium bovis: characteristics of wildlife reservoir hosts | Q38156491 | ||
The BCG replacement vaccine VPM1002: from drawing board to clinical trial | Q38202181 | ||
Tuberculosis in domestic animal species. | Q38242715 | ||
The formation of the granuloma in tuberculosis infection | Q38276831 | ||
T cells and adaptive immunity to Mycobacterium tuberculosis in humans | Q38363792 | ||
Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs | Q38447094 | ||
IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages | Q39734138 | ||
Drosophila melanogaster is a genetically tractable model host for Mycobacterium marinum | Q39755163 | ||
New approaches to tuberculosis surveillance in nonhuman primates | Q40116215 | ||
Function and mechanism of action of Dictyostelium Nramp1 (Slc11a1) in bacterial infection. | Q40323441 | ||
Early events in Mycobacterium tuberculosis infection in cynomolgus macaques | Q41476956 | ||
Establishment of a rabbit model of spinal tuberculosis using Mycobacterium tuberculosis strain H37Rv | Q41650591 | ||
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns | Q41775340 | ||
TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species | Q41816750 | ||
Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model | Q41981914 | ||
THE FATE OF HUMAN AND BOVINE TUBERCLE BACILLI IN VARIOUS ORGANS OF THE RABBIT. | Q42108589 | ||
Efferocytosis is an innate antibacterial mechanism | Q42397749 | ||
Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos | Q43464391 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tuberculosis | Q12204 |
P304 | page(s) | 871-883 | |
P577 | publication date | 2015-06-13 | |
P1433 | published in | Expert Opinion on Drug Discovery | Q5421204 |
P1476 | title | Animal models in tuberculosis research - where is the beef? | |
P478 | volume | 10 |
Q40179059 | A Novel In Vitro Human Granuloma Model of Sarcoidosis and Latent TB Infection |
Q38681974 | Animal Models for Tuberculosis in Translational and Precision Medicine. |
Q89560388 | Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis |
Q59073293 | Challenges and recent progress in drug discovery for tropical diseases |
Q40190981 | Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine. |
Q40089850 | Experimental study of tuberculosis: From animal models to complex cell systems and organoids. |
Q91868229 | Galleria mellonella: An Infection Model for Screening Compounds Against the Mycobacterium tuberculosis Complex |
Q40120455 | Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio). |
Q54246706 | Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish. |
Q61442973 | Intelectin 3 is dispensable for resistance against a mycobacterial infection in zebrafish (Danio rerio) |
Q63369779 | Interleukin 10 mutant zebrafish have an enhanced interferon gamma response and improved survival against a Mycobacterium marinum infection |
Q96162630 | Preclinical models to optimize treatment of tuberculous meningitis - A systematic review |
Q48172985 | Priming of innate antimycobacterial immunity by heat-killed Listeria monocytogenes induces sterilizing response in the adult zebrafish tuberculosis model |
Q37000830 | Quantifying Limits on Replication, Death, and Quiescence of Mycobacterium tuberculosis in Mice |
Q36032597 | The FBPase Encoding Gene glpX Is Required for Gluconeogenesis, Bacterial Proliferation and Division In Vivo of Mycobacterium marinum. |
Q26744620 | The Zebrafish Breathes New Life into the Study of Tuberculosis |
Search more.